Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Moldenhauer

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|July 15, 1987
Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancyP Möller, B Herrmann, G Moldenhauer, et al.
Leukemia|November 1, 1996
Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibodyM Csóka, G Strauss, K M Debatin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1988
The B cell-associated CD37 antigen (gp40-52). Structure and subcellular expression of an extensively glycosylated glycoproteinR Schwartz-Albiez, B Dörken, W Hofmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1991
Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74)N Koch, G Moldenhauer, W J Hofmann, et al.
International Journal of Cancer|August 4, 1998
Bispecific CD3 x CD19 diabody for T cell-mediated lysis of malignant human B cellsS M Kipriyanov, G Moldenhauer, G Strauss, et al.
Journal of Immunogenetics|April 1, 1986
Loss of HLA-A,B,C in colorectal carcinoma is related to the degree of de-differentiationF Momburg, P Möller, G Moldenhauer, et al.
Cancer Research|June 1, 1987
Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissuesF Momburg, G Moldenhauer, G J Hämmerling, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1987
Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140A Pezzutto, B Dörken, G Moldenhauer, et al.
Immunology Today|August 1, 2000
Of mice and men: hybridoma and recombinant antibodiesM Little, S M Kipriyanov, F Le Gall, et al.
FEBS Letters|July 14, 1999
Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell bindingF Le Gall, S M Kipriyanov, G Moldenhauer, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|July 15, 1987
Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancyP Möller, B Herrmann, G Moldenhauer, et al.
Leukemia|November 1, 1996
Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibodyM Csóka, G Strauss, K M Debatin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1988
The B cell-associated CD37 antigen (gp40-52). Structure and subcellular expression of an extensively glycosylated glycoproteinR Schwartz-Albiez, B Dörken, W Hofmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1991
Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74)N Koch, G Moldenhauer, W J Hofmann, et al.
International Journal of Cancer|August 4, 1998
Bispecific CD3 x CD19 diabody for T cell-mediated lysis of malignant human B cellsS M Kipriyanov, G Moldenhauer, G Strauss, et al.
Journal of Immunogenetics|April 1, 1986
Loss of HLA-A,B,C in colorectal carcinoma is related to the degree of de-differentiationF Momburg, P Möller, G Moldenhauer, et al.
Cancer Research|June 1, 1987
Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissuesF Momburg, G Moldenhauer, G J Hämmerling, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1987
Amplification of human B cell activation by a monoclonal antibody to the B cell-specific antigen CD22, Bp 130/140A Pezzutto, B Dörken, G Moldenhauer, et al.
Immunology Today|August 1, 2000
Of mice and men: hybridoma and recombinant antibodiesM Little, S M Kipriyanov, F Le Gall, et al.
FEBS Letters|July 14, 1999
Di-, tri- and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell bindingF Le Gall, S M Kipriyanov, G Moldenhauer, et al.
Pageof 13